This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, H Y Articles by Staines, N A Search for Related Content PubMed PubMed Citation Articles by Wu, H Y Articles by Staines, N A Social Bookmarking                   What's this?

A deficiency of CD4+ CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen

The Infection and Immunity Research Group, Franklin-Wilkins Building, King’s College London, London, UK, hwu{at}rics.bwh.harvard.edu

N A Staines

The Infection and Immunity Research Group, Franklin-Wilkins Building, King’s College London, London, UK

It has been repeatedly shown that a subset of CD4⁺ T cells that constitutively express CD25 on their surface plays a role in the maintenanceof self-tolerance.They may directly or indirectly affect the development of autoimmunity in susceptible mice and humans. In this study, we examine the relationship between the percentage of peripheral CD4⁺CD25⁺ T cells and the state of disease in spontaneous models of autoimmune disease. We found that both BWF1 and SNF1 mice that spontaneously develop a lupus-like disease have inherently lower percentage of the CD4⁺CD25⁺ T cells in their CD4 repertoire compared with normal Balb/c and DBA/1 mice. The percentage of CD4⁺CD25⁺ T cells was found to be increased in both normal and lupus-pronemice as they reached 7 to 8 months of age. However, mice with an autoimmune backgrounddiffered from mice on a normal background in that the number of CD4⁺CD25⁺ T cells never reached 5% of the CD4 population.The lower number of the CD4⁺CD25⁺ T cells in autoimmune mice was restored to the level seen in normal mice following administration of histone peptide H471 or OVA(323-339) peptide in the absence of adjuvant intranasally but not intradermally. As such transmucosal treatment may ameliorate disease, we conclude that a deficiency in the CD4⁺CD25⁺ T cell pool contributesto a susceptibilityto develop spontaneous lupus disease.

Key Words: CD4+CD25+ T cells • histone peptide • nasal tolerance • spontaneous lupus

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Bonelli, A. Savitskaya, K. von Dalwigk, C. W. Steiner, D. Aletaha, J. S. Smolen, and C. Scheinecker Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE) Int. Immunol., July 1, 2008; 20(7): 861 - 868. [Abstract] [Full Text] [PDF]

				A Kuhn and M Bijl Pathogenesis of cutaneous lupus erythematosus Lupus, May 1, 2008; 17(5): 389 - 393. [Abstract] [PDF]

				F. Carlucci, J. Cortes-Hernandez, L. Fossati-Jimack, A. E. Bygrave, M. J. Walport, T. J. Vyse, H. T. Cook, and M. Botto Genetic Dissection of Spontaneous Autoimmunity Driven by 129-Derived Chromosome 1 Loci When Expressed on C57BL/6 Mice J. Immunol., February 15, 2007; 178(4): 2352 - 2360. [Abstract] [Full Text] [PDF]

				K. J. Scalapino, Q. Tang, J. A. Bluestone, M. L. Bonyhadi, and D. I. Daikh Suppression of Disease in New Zealand Black/New Zealand White Lupus-Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells J. Immunol., August 1, 2006; 177(3): 1451 - 1459. [Abstract] [Full Text] [PDF]

				A. Sharabi, H. Zinger, M. Zborowsky, Z. M. Sthoeger, and E. Mozes A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta PNAS, June 6, 2006; 103(23): 8810 - 8815. [Abstract] [Full Text] [PDF]

				J A Hardin Dendritic cells: potential triggers of autoimmunity and targets for therapy Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv86 - iv90. [Full Text] [PDF]